Edward Conner
Chief Tech/Sci/R&D Officer at THIRD HARMONIC BIO, INC.
Net worth: - $ as of 2024-04-29
Edward Conner active positions
| Companies | Position | Start | End |
|---|---|---|---|
| THIRD HARMONIC BIO, INC. | Chief Tech/Sci/R&D Officer | 2022-05-31 | - |
Career history of Edward Conner
Former positions of Edward Conner
| Companies | Position | Start | End |
|---|---|---|---|
| IMARA | Director/Board Member | 2020-04-21 | 2023-02-23 |
| Independent Dir/Board Member | 2020-04-21 | 2023-02-23 | |
Locanabio, Inc.
 Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 2021-06-30 | 2022-05-31 |
| AUDENTES THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-05-14 | - |
| Corporate Officer/Principal | - | 2021-06-30 | |
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2016-10-31 | 2019-05-30 |
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 2014-12-31 | 2016-09-30 |
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 2013-09-30 | 2014-10-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 2007-12-31 | 2012-12-31 |
Training of Edward Conner
| The University of California, San Francisco | Doctorate Degree |
| Duke University | Undergraduate Degree |
Statistics
International
| United States | 11 |
Operational
| Chief Tech/Sci/R&D Officer | 6 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| THIRD HARMONIC BIO, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA. | Health Technology |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Technology Services |
- Stock Market
- Insiders
- Edward Conner
- Experience
